{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:01:37Z","timestamp":1780718497440,"version":"3.54.1"},"reference-count":34,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej26-0092","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:14:21Z","timestamp":1776291261000},"page":"667-675","source":"Crossref","is-referenced-by-count":0,"title":["Insights from maturity-onset diabetes of the young into impaired insulin secretion in type 2 diabetes"],"prefix":"10.1507","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7268-6871","authenticated-orcid":false,"given":"Yukio","family":"Horikawa","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Gifu University, Graduate School of Medicine, Gifu 501-1194, Japan"},{"name":"Clinical Genetics Center, Gifu University Hospital, Gifu 501-1194, Japan"},{"name":"Present affiliation: Center for Genomic and Precision Medicine, Center for Preventive and Personalized Medicine, Central Japan International Medical Center, 1-1 Kenkonomachi, Minokamo, Gifu 505-8510, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4841-9914","authenticated-orcid":false,"given":"Yoshihiro","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Gifu University, Graduate School of Medicine, Gifu 501-1194, Japan"},{"name":"Clinical Genetics Center, Gifu University Hospital, Gifu 501-1194, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2712-1825","authenticated-orcid":false,"given":"Kazuyoshi","family":"Hosomichi","sequence":"additional","affiliation":[{"name":"Laboratory of Computational Genomics, Tokyo University of Pharmacy and Life Sciences, Tokyo 192-0392, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Horikawa Y, Hosomichi K, Yabe D (2024) Monogenic diabetes. Diabetol Int 15: 679\u2013687.","DOI":"10.1007\/s13340-024-00698-6"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2 Fajans SS, Bell GI (2011) MODY: history, genetics, pathophysiology, and clinical decision making. Diabetes Care 34: 1878\u20131884.","DOI":"10.2337\/dc11-0035"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Horikawa Y (2018) Maturity-onset diabetes of the young as a model for elucidating the multifactorial origin of type 2 diabetes mellitus. J Diabetes Investig 9: 704\u2013712.","DOI":"10.1111\/jdi.12812"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Yoshiji S, Hasebe M, Tanaka D, Shimizu M, Soma Y, et al. (2026) Genetic and clinical characteristics of monogenic diabetes in Japan: a nationwide study by the Japan Diabetes Society. J Clin Endocrinol Metab 111: 757\u2013769.","DOI":"10.1210\/clinem\/dgaf478"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Timsit J, Ciangura C, Dubois-Laforgue D, Saint-Martin C, Bellanne-Chantelot C (2022) Pregnancy in women with monogenic diabetes due to pathogenic variants of the glucokinase gene: lessons and challenges. Front Endocrinol (Lausanne) 12: 802423.","DOI":"10.3389\/fendo.2021.802423"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Chakera AJ, Steele AM, Gloyn AL, Shepherd MH, Shields B, et al. (2015) Recognition and management of individuals with hyperglycemia because of a heterozygous glucokinase mutation. Diabetes Care 38: 1383\u20131392.","DOI":"10.2337\/dc14-2769"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7 Steele AM, Shields BM, Wensley KJ, Colclough K, Ellard S, et al. (2014) Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia. JAMA 311: 279\u2013286.","DOI":"10.1001\/jama.2013.283980"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Scotchman E, Chandler NJ, Mellis R, Chitty LS (2020) Noninvasive prenatal diagnosis of single-gene diseases: the next frontier. Clin Chem 66: 53\u201360.","DOI":"10.1373\/clinchem.2019.304238"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Cho J, Horikawa Y, Enya M, Takeda J, Imai Y, et al. (2020) L-Arginine prevents cereblon-mediated ubiquitination of glucokinase and stimulates glucose-6-phosphate production in pancreatic \u03b2-cells. Commun Biol 3: 497.","DOI":"10.1038\/s42003-020-01226-3"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Cho J, Horikawa Y, Oiwa Y, Hosomichi K, Yabe D, et al. (2023) Glucokinase variant proteins are resistant to fasting-induced uridine diphosphate glucose-dependent degradation in maturity-onset diabetes of the young type 2 patients. Int J Mol Sci 24: 15842.","DOI":"10.3390\/ijms242115842"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Bellann\u00e9-Chantelot C, L\u00e9vy DJ, Carette C, Saint-Martin C, Riveline JP, et al. (2011) Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene. J Clin Endocrinol Metab 96: E1346\u2013E1351.","DOI":"10.1210\/jc.2011-0268"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Horikawa Y, Enya M, Fushimi N, Fushimi Y, Takeda J (2014) Screening of diabetes of youth for hepatocyte nuclear factor 1 mutations: clinical phenotype of HNF1\u03b2-related maturity-onset diabetes of the young and HNF1\u03b1-related maturity-onset diabetes of the young in Japanese. Diabet Med 31: 721\u2013727.","DOI":"10.1111\/dme.12416"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Maagensen H, Jensen JS, H\u00f8yerup SO, Thuesen ACB, Krogh J, et al. (2025) Effect of SGLT2 inhibition on glucosuria during a hyperglycemic clamp in HNF1A-MODY (MODY3) and type 2 diabetes. Diabetes Care 48: 1536\u20131544.","DOI":"10.2337\/dc25-0737"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 McDonald TJ, Shields BM, Lawry J, Owen KR, Gloyn AL, et al. (2011) High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes. Diabetes Care 34: 1860\u20131862.","DOI":"10.2337\/dc11-0323"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Yang C, Ji L, Han X (2025) Low C-reactive protein alleles in hepatocyte nuclear factor 1A are associated with an increased risk of cardiovascular disease. J Clin Endocrinol Metab 110: 592\u2013600.","DOI":"10.1210\/clinem\/dgae602"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16 Pearson ER, Starkey BJ, Powell RJ, Gribble FM, Clark PM, et al. (2003) Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 362: 1275\u20131281.","DOI":"10.1016\/S0140-6736(03)14571-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Fu J, Wang T, Zhai X, Xiao X (2020) Primary hepatocellular adenoma due to biallelic HNF1A mutations and its co-occurrence with MODY 3: case-report and review of the literature. Endocrine 67: 544\u2013551.","DOI":"10.1007\/s12020-019-02138-x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Richter S, Shih DQ, Pearson ER, Wolfrum C, Fajans SS, et al. (2003) Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Diabetes 52: 2989\u20132995.","DOI":"10.2337\/diabetes.52.12.2989"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Buffin-Meyer B, Richard J, Guigonis V, Weber S, K\u00f6nig J, et al. (2024) Renal and extrarenal phenotypes in patients with HNF1B variants and chromosome 17q12 microdeletions. Kidney Int Rep 9: 2514\u20132526.","DOI":"10.1016\/j.ekir.2024.05.007"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Fontana P, Costabile C, Falco M, Barillari MR, Lonardo F (2025) MODY5 and 17q12 microdeletion syndrome: phenotype variability, prenatal and postnatal counseling. Genes (Basel) 16: 1002.","DOI":"10.3390\/genes16091002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Cannon S, Clissold R, Sukcharoen K, Tuke M, Hawkes G, et al. (2023) Recurrent 17q12 microduplications contribute to renal disease but not diabetes. J Med Genet 60: 491\u2013497.","DOI":"10.1136\/jmg-2022-108615"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Pearson ER, Boj SF, Steele AM, Barrett T, Stals K, et al. (2007) Macrosomia and hyperinsulinaemic hypoglycaemia in patients with heterozygous mutations in the HNF4A gene. PLoS Med 4: e118.","DOI":"10.1371\/journal.pmed.0040118"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Horikawa Y, Enya M, Mabe H, Fukushima K, Takubo N, et al. (2018) NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features. Pediatr Diabetes 19: 236\u2013242.","DOI":"10.1111\/pedi.12553"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Horikawa Y, Enya M (2019) Genetic dissection and clinical features of MODY6 (NEUROD1-MODY). Curr Diab Rep 19: 12.","DOI":"10.1007\/s11892-019-1130-9"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Yoshiji S, Horikawa Y, Kubota S, Enya M, Iwasaki Y, et al. (2021) First Japanese family with PDX1-MODY (MODY4): a novel PDX1 frameshift mutation, clinical characteristics, and implications. J Endocr Soc 6: bvab159.","DOI":"10.1210\/jendso\/bvab159"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26 Sharp LN, Colclough K, Murray Leech J, Cannon SJ, Laver TW, et al. (2025) Population prevalence, penetrance, and mortality for genetically confirmed MODY. J Clin Endocrinol Metab doi: 10.1210\/clinem\/dgaf599. Online ahead of print.","DOI":"10.1210\/clinem\/dgaf599"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Laver TW, Wakeling MN, Knox O, Colclough K, Wright CF, et al. (2022) Evaluation of evidence for pathogenicity demonstrates that BLK, KLF11, and PAX4 should not be included in diagnostic testing for MODY. Diabetes 71: 1128\u20131136.","DOI":"10.2337\/db21-0844"},{"key":"28","doi-asserted-by":"publisher","unstructured":"28 Shields BM, McDonald TJ, Ellard S, Campbell MJ, Hyde C, et al. (2012) The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia 55: 1265\u20131272.","DOI":"10.1007\/s00125-011-2418-8"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Knupp J, Cardoso P, Young KG, McDonald TJ, Patel KA, et al. (2025) Updating a clinical prediction model for identifying monogenic diabetes to include both clinical features and biomarkers. Diabetes Care 49: 589\u2013597.","DOI":"10.2337\/dc25-1029"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Horikawa Y, Hosomichi K, Enya M, Ishiura H, Suzuki Y, et al. (2018) No novel, high penetrant gene might remain to be found in Japanese patients with unknown MODY. J Hum Genet 63: 821\u2013829.","DOI":"10.1038\/s10038-018-0449-4"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31 Spracklen CN, Horikoshi M, Kim YJ, Lin K, Bragg F, et al. (2020) Identification of type 2 diabetes loci in 433,540 East Asian individuals. Nature 582: 240\u2013245.","DOI":"10.1038\/s41586-020-2263-3"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Suzuki K, Hatzikotoulas K, Southam L, Taylor HJ, Yin X, et al. (2024) Genetic drivers of heterogeneity in type 2 diabetes pathophysiology. Nature 627: 347\u2013357.","DOI":"10.1038\/s41586-024-07019-6"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Najmi LA, Aukrust I, Flannick J, Molnes J, Burtt N, et al. (2017) Functional investigations of HNF1A identify rare variants as risk factors for type 2 diabetes in the general population. Diabetes 66: 335\u2013346.","DOI":"10.2337\/db16-0460"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Bonnefond A, Boissel M, Bolze A, Durand E, Toussaint B, et al. (2020) Pathogenic variants in actionable MODY genes are associated with type 2 diabetes. Nat Metab 2: 1126\u20131134.","DOI":"10.1038\/s42255-020-00294-3"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/6\/73_EJ26-0092\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:23:04Z","timestamp":1780716184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/6\/73_EJ26-0092\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej26-0092","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ26-0092"}}